Carob Extract (Ceratonia siliqua L.): Effects on Dyslipidemia and Obesity in a High-Fat Diet-Fed Rat Model
Autori
Rašković, AleksandarMartić, Nikola
Tomas, Ana
Andrejić-Višnjić, Bojana
Bosanac, Milana
Atanasković, Marko
Nemet, Marko
Popović, Radmila
Krstić, Marko
Vukmirović, Saša
Stilinović, Nebojša
Članak u časopisu (Objavljena verzija)
Metapodaci
Prikaz svih podataka o dokumentuApstrakt
Dyslipidemia and obesity are recognized as two of the major global health issues and main risk factors for coronary heart disease and cerebrovascular disease. In recent years, carob has shown certain antioxidant and anti-dyslipidemic potential. In this study, Wistar rats were fed with a standard and cholesterol-enriched diet and treated orally with carob extract and simvastatin for four weeks. After sacrifice, blood samples were collected for biochemical analysis, and liver tissue was taken for histological and immunohistochemical assessment. Weight gain was significantly higher in groups fed with cholesterol-fortified granules; total cholesterol was found to be significantly lower in the hypercholesterolemic groups treated with simvastatin and simvastatin/carob combined regimens compared with hypercholesterolemic animals treated with saline (p < 0.05). The same was true for low-density lipoprotein cholesterol and the LDL/HDL ratio (p < 0.05). Adiponectin was remarkably higher in anima...ls treated with simvastatin compared to all other groups (p < 0.05). Leptin was significantly lower in groups treated with carob and simvastatin compared to the hypercholesterolemic group treated with saline (p < 0.05). Carob/simvastatin co-administration reduced hepatocyte damage and improved liver morphology. A study confirmed the anti-dyslipidemic, anti-obesity, and hepatoprotective potential of carob pulp alone or in combination with simvastatin in the treatment of high-fat diet-fed rats.
Ključne reči:
adiponectin / carob extract / CYP2E1 / dyslipidemia / high-fat diet-fed rat model / Iba1 / leptin / obesityIzvor:
Pharmaceutics, 2023, 15, 11, 2611-Izdavač:
- MDPI
Finansiranje / projekti:
- Provincial Secretariat for Higher Education and Scientific Research of Vojvodina
Kolekcije
Institucija/grupa
Hemijski fakultet / Faculty of ChemistryTY - JOUR AU - Rašković, Aleksandar AU - Martić, Nikola AU - Tomas, Ana AU - Andrejić-Višnjić, Bojana AU - Bosanac, Milana AU - Atanasković, Marko AU - Nemet, Marko AU - Popović, Radmila AU - Krstić, Marko AU - Vukmirović, Saša AU - Stilinović, Nebojša PY - 2023 UR - http://cherry.chem.bg.ac.rs/handle/123456789/6396 AB - Dyslipidemia and obesity are recognized as two of the major global health issues and main risk factors for coronary heart disease and cerebrovascular disease. In recent years, carob has shown certain antioxidant and anti-dyslipidemic potential. In this study, Wistar rats were fed with a standard and cholesterol-enriched diet and treated orally with carob extract and simvastatin for four weeks. After sacrifice, blood samples were collected for biochemical analysis, and liver tissue was taken for histological and immunohistochemical assessment. Weight gain was significantly higher in groups fed with cholesterol-fortified granules; total cholesterol was found to be significantly lower in the hypercholesterolemic groups treated with simvastatin and simvastatin/carob combined regimens compared with hypercholesterolemic animals treated with saline (p < 0.05). The same was true for low-density lipoprotein cholesterol and the LDL/HDL ratio (p < 0.05). Adiponectin was remarkably higher in animals treated with simvastatin compared to all other groups (p < 0.05). Leptin was significantly lower in groups treated with carob and simvastatin compared to the hypercholesterolemic group treated with saline (p < 0.05). Carob/simvastatin co-administration reduced hepatocyte damage and improved liver morphology. A study confirmed the anti-dyslipidemic, anti-obesity, and hepatoprotective potential of carob pulp alone or in combination with simvastatin in the treatment of high-fat diet-fed rats. PB - MDPI T2 - Pharmaceutics T1 - Carob Extract (Ceratonia siliqua L.): Effects on Dyslipidemia and Obesity in a High-Fat Diet-Fed Rat Model VL - 15 IS - 11 SP - 2611 DO - 10.3390/pharmaceutics15112611 ER -
@article{ author = "Rašković, Aleksandar and Martić, Nikola and Tomas, Ana and Andrejić-Višnjić, Bojana and Bosanac, Milana and Atanasković, Marko and Nemet, Marko and Popović, Radmila and Krstić, Marko and Vukmirović, Saša and Stilinović, Nebojša", year = "2023", abstract = "Dyslipidemia and obesity are recognized as two of the major global health issues and main risk factors for coronary heart disease and cerebrovascular disease. In recent years, carob has shown certain antioxidant and anti-dyslipidemic potential. In this study, Wistar rats were fed with a standard and cholesterol-enriched diet and treated orally with carob extract and simvastatin for four weeks. After sacrifice, blood samples were collected for biochemical analysis, and liver tissue was taken for histological and immunohistochemical assessment. Weight gain was significantly higher in groups fed with cholesterol-fortified granules; total cholesterol was found to be significantly lower in the hypercholesterolemic groups treated with simvastatin and simvastatin/carob combined regimens compared with hypercholesterolemic animals treated with saline (p < 0.05). The same was true for low-density lipoprotein cholesterol and the LDL/HDL ratio (p < 0.05). Adiponectin was remarkably higher in animals treated with simvastatin compared to all other groups (p < 0.05). Leptin was significantly lower in groups treated with carob and simvastatin compared to the hypercholesterolemic group treated with saline (p < 0.05). Carob/simvastatin co-administration reduced hepatocyte damage and improved liver morphology. A study confirmed the anti-dyslipidemic, anti-obesity, and hepatoprotective potential of carob pulp alone or in combination with simvastatin in the treatment of high-fat diet-fed rats.", publisher = "MDPI", journal = "Pharmaceutics", title = "Carob Extract (Ceratonia siliqua L.): Effects on Dyslipidemia and Obesity in a High-Fat Diet-Fed Rat Model", volume = "15", number = "11", pages = "2611", doi = "10.3390/pharmaceutics15112611" }
Rašković, A., Martić, N., Tomas, A., Andrejić-Višnjić, B., Bosanac, M., Atanasković, M., Nemet, M., Popović, R., Krstić, M., Vukmirović, S.,& Stilinović, N.. (2023). Carob Extract (Ceratonia siliqua L.): Effects on Dyslipidemia and Obesity in a High-Fat Diet-Fed Rat Model. in Pharmaceutics MDPI., 15(11), 2611. https://doi.org/10.3390/pharmaceutics15112611
Rašković A, Martić N, Tomas A, Andrejić-Višnjić B, Bosanac M, Atanasković M, Nemet M, Popović R, Krstić M, Vukmirović S, Stilinović N. Carob Extract (Ceratonia siliqua L.): Effects on Dyslipidemia and Obesity in a High-Fat Diet-Fed Rat Model. in Pharmaceutics. 2023;15(11):2611. doi:10.3390/pharmaceutics15112611 .
Rašković, Aleksandar, Martić, Nikola, Tomas, Ana, Andrejić-Višnjić, Bojana, Bosanac, Milana, Atanasković, Marko, Nemet, Marko, Popović, Radmila, Krstić, Marko, Vukmirović, Saša, Stilinović, Nebojša, "Carob Extract (Ceratonia siliqua L.): Effects on Dyslipidemia and Obesity in a High-Fat Diet-Fed Rat Model" in Pharmaceutics, 15, no. 11 (2023):2611, https://doi.org/10.3390/pharmaceutics15112611 . .